Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.
Authors: Garey KW; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Jo J; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Gonzales-Luna AJ; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Lapin B; Cleveland Clinic, Cleveland, Ohio., Deshpande A; Cleveland Clinic, Cleveland, Ohio., Wang E; Seres Therapeutics, Inc, Cambridge, Massachusetts., Hasson B; Seres Therapeutics, Inc, Cambridge, Massachusetts., Pham SV; AESARA, Inc, Chapel Hill, North Carolina., Huang SP; AESARA, Inc, Chapel Hill, North Carolina., Reese PR; Apex, North Carolina., Wu H; CR Medicon, Piscataway, New Jersey., Hohmann E; Massachusetts General Hospital, Boston., Feuerstadt P; Yale University School of Medicine, New Haven, Connecticut.; PACT-Gastroenterology Center, Hamden, Connecticut., Oneto C; Vanguard Gastroenterology, New York, New York., Berenson CS; University at Buffalo, VA Western New York Healthcare System, Buffalo., Lee C; University of British Columbia, British Columbia, Canada.; Island Medical Program, University of Victoria, British Columbia, Canada., McGovern B; Seres Therapeutics, Inc, Cambridge, Massachusetts., vonMoltke L; Seres Therapeutics, Inc, Cambridge, Massachusetts.
Source: JAMA network open [JAMA Netw Open] 2023 Jan 03; Vol. 6 (1), pp. e2253570. Date of Electronic Publication: 2023 Jan 03.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36716031
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garey+KW%22">Garey KW</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Jo+J%22">Jo J</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gonzales-Luna+AJ%22">Gonzales-Luna AJ</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Lapin+B%22">Lapin B</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Deshpande+A%22">Deshpande A</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hasson+B%22">Hasson B</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pham+SV%22">Pham SV</searchLink>; AESARA, Inc, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Huang+SP%22">Huang SP</searchLink>; AESARA, Inc, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Reese+PR%22">Reese PR</searchLink>; Apex, North Carolina.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; CR Medicon, Piscataway, New Jersey.<br /><searchLink fieldCode="AU" term="%22Hohmann+E%22">Hohmann E</searchLink>; Massachusetts General Hospital, Boston.<br /><searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; Yale University School of Medicine, New Haven, Connecticut.; PACT-Gastroenterology Center, Hamden, Connecticut.<br /><searchLink fieldCode="AU" term="%22Oneto+C%22">Oneto C</searchLink>; Vanguard Gastroenterology, New York, New York.<br /><searchLink fieldCode="AU" term="%22Berenson+CS%22">Berenson CS</searchLink>; University at Buffalo, VA Western New York Healthcare System, Buffalo.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; University of British Columbia, British Columbia, Canada.; Island Medical Program, University of Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22McGovern+B%22">McGovern B</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22vonMoltke+L%22">vonMoltke L</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2023 Jan 03; Vol. 6 (1), pp. e2253570. <i>Date of Electronic Publication: </i>2023 Jan 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36716031
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamanetworkopen.2022.53570
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2253570
    Titles:
      – TitleFull: Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garey KW
      – PersonEntity:
          Name:
            NameFull: Jo J
      – PersonEntity:
          Name:
            NameFull: Gonzales-Luna AJ
      – PersonEntity:
          Name:
            NameFull: Lapin B
      – PersonEntity:
          Name:
            NameFull: Deshpande A
      – PersonEntity:
          Name:
            NameFull: Wang E
      – PersonEntity:
          Name:
            NameFull: Hasson B
      – PersonEntity:
          Name:
            NameFull: Pham SV
      – PersonEntity:
          Name:
            NameFull: Huang SP
      – PersonEntity:
          Name:
            NameFull: Reese PR
      – PersonEntity:
          Name:
            NameFull: Wu H
      – PersonEntity:
          Name:
            NameFull: Hohmann E
      – PersonEntity:
          Name:
            NameFull: Feuerstadt P
      – PersonEntity:
          Name:
            NameFull: Oneto C
      – PersonEntity:
          Name:
            NameFull: Berenson CS
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: McGovern B
      – PersonEntity:
          Name:
            NameFull: vonMoltke L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 01
              Text: 2023 Jan 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2574-3805
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: JAMA network open
              Type: main
ResultId 1